Dare Bioscience Inc (DARE)

May 04, 2026

12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga

May 04, 2026

Apr 28, 2026

Dare Bioscience | DEFA14A: Others - Moomoo

Apr 28, 2026

Apr 28, 2026

Form ARS Dare Bioscience, Inc. For: Dec 31 - StreetInsider

Apr 28, 2026

Apr 28, 2026

Daré Bioscience (DARE) seeks approval for Lincoln Park share facility and 1.5M-plan increase - Stock Titan

Apr 28, 2026

Apr 27, 2026

Daré outlines expanded dual path strategy targeting $4.5B hormone therapy market while accelerating commercialization in Q4 2025 - MSN

Apr 27, 2026

Apr 26, 2026

Dare Bioscience FY 2025 earnings preview - MSN

Apr 26, 2026

Apr 23, 2026

Daré Bioscience Posts Updated Corporate Investor Presentation Online - The Globe and Mail

Apr 23, 2026

Apr 22, 2026

Daré Bioscience (DARE) posts updated corporate investor presentation - Stock Titan

Apr 22, 2026

Apr 21, 2026

Dare Bioscience completes closing of Regulation A offering of preferred stock and warrants - Investing.com UK

Apr 21, 2026

Apr 20, 2026

Daré Bioscience Completes Regulation A Preferred Stock Offering - TipRanks

Apr 20, 2026

Apr 20, 2026

Daré Bioscience (NASDAQ: DARE) closes 20,000-unit Regulation A sale - Stock Titan

Apr 20, 2026

Apr 19, 2026

DARE Surges As Daré Bioscience Unveils Women’s Health Catalysts - StocksToTrade

Apr 19, 2026

Apr 19, 2026

DARE Surges As Daré Bioscience Launches Women’s Sildenafil Cream - timothysykes.com

Apr 19, 2026

Apr 18, 2026

DARE Bioscience Jumps As DARE to PLAY Launch and Pipeline Catalysts Draw Focus - StocksToTrade

Apr 18, 2026

Apr 18, 2026

DARE Bioscience Jumps As DARE to PLAY Launch Highlights Catalyst Path - timothysykes.com

Apr 18, 2026

Apr 17, 2026

Daré Bioscience Rebalances Classified Board Structure and Terms - TipRanks

Apr 17, 2026

Apr 17, 2026

Daré Bioscience (DARE) reclassifies director to rebalance staggered board - Stock Titan

Apr 17, 2026

Apr 17, 2026

Daré Bioscience (NASDAQ: DARE) asks shareholders to approve 1.5M plan shares, vote June 11 - Stock Titan

Apr 17, 2026

Apr 16, 2026

12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga

Apr 16, 2026

Apr 15, 2026

DARE Technical Analysis | Trend, Signals & Chart Patterns | DARE BIOSCIENCE INC (NASDAQ:DARE) - ChartMill

Apr 15, 2026

Apr 14, 2026

Dare Bioscience completes closing of Regulation A equity offering By Investing.com - Investing.com Australia

Apr 14, 2026

Apr 14, 2026

DARÉ BIOSCIENCE, INC. Files Form 8-K Report with SEC for Unregistered Sales of Equity Securities – April 2026 - Minichart

Apr 14, 2026

Apr 13, 2026

Dare Bioscience completes closing of Regulation A equity offering - Investing.com

Apr 13, 2026

Apr 13, 2026

Daré Bioscience (NASDAQ: DARE) closes Regulation A sale of 3,470 units - Stock Titan

Apr 13, 2026

Apr 11, 2026

Maxim Group Maintains Dare Bioscience(DARE.US) With Buy Rating, Maintains Target Price $8 - Moomoo

Apr 11, 2026

Apr 07, 2026

LEXX Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI

Apr 07, 2026

Apr 03, 2026

Head-To-Head Review: Dare Bioscience (NASDAQ:DARE) & Appili Therapeutics (OTCMKTS:APLIF) - Defense World

Apr 03, 2026

Apr 01, 2026

Maxim Group Upgrades Daré Bioscience (DARE) - MSN

Apr 01, 2026

Apr 01, 2026

Dare Bioscience | QUALIF: Others - Moomoo

Apr 01, 2026

Mar 28, 2026

Dare Bioscience, Inc. (DARE) reports Q4 loss, lags revenue estimates - MSN

Mar 28, 2026

Mar 27, 2026

Daré Bioscience Reports Full Year 2025 Financial Results and Provides Business Update - The Manila Times

Mar 27, 2026

Mar 26, 2026

Dare Bioscience Q4 2025 Earnings Call Transcript - MarketBeat

Mar 26, 2026

Mar 26, 2026

Transcript : Daré Bioscience, Inc., 2025 Earnings Call, Mar 26, 2026 - marketscreener.com

Mar 26, 2026

Mar 26, 2026

Dare Bioscience, Inc. (DARE) Announces Fourth Quarter Loss, Falls Short of Revenue Expectations - Bitget

Mar 26, 2026

Mar 26, 2026

Dare Bioscience Inc reports results for the quarter ended December 31Earnings Summary - TradingView — Track All Markets

Mar 26, 2026

Mar 26, 2026

Earnings call transcript: Daré Bioscience Q4 2025 highlights capital efficiency By Investing.com - Investing.com India

Mar 26, 2026

Mar 26, 2026

Earnings call transcript: Daré Bioscience Q4 2025 highlights capital efficiency - Investing.com

Mar 26, 2026

Mar 26, 2026

Dare Bioscience, Inc. (DARE) Reports Q4 Loss, Lags Revenue Estimates - Yahoo Finance

Mar 26, 2026

Mar 26, 2026

Daré Bioscience, Inc. 2025 Q4ResultsEarnings Call Presentation (NASDAQ:DARE) 2026-03-26 - Seeking Alpha

Mar 26, 2026

Mar 26, 2026

Q4 2025 Dare Bioscience Inc Earnings Call Transcript - GuruFocus

Mar 26, 2026

Mar 26, 2026

Daré Bioscience (NASDAQ: DARE) expands dual-path women’s health model - Stock Titan

Mar 26, 2026

Mar 26, 2026

Daré Bioscience (NASDAQ: DARE) details 2025 loss, funding boost and upcoming product launches - stocktitan.net

Mar 26, 2026

Mar 26, 2026

DARE: DARE to PLAY launches nationwide, with multi-product revenue growth expected in 2026-2027 - TradingView

Mar 26, 2026

Mar 26, 2026

Dare Bioscience Inc (DARE) Q4 2025 Earnings Report Preview: What To Expect - GuruFocus

Mar 26, 2026

Mar 24, 2026

Dare Bioscience Inc expected to post a loss of 43 cents a shareEarnings Preview - TradingView

Mar 24, 2026

Mar 23, 2026

A Viagra ingredient is now in a topical cream developed for women - Stock Titan

Mar 23, 2026

Mar 23, 2026

On National Viagra Day, Women Finally Claim Their Turn: - Bitget

Mar 23, 2026

Mar 23, 2026

Dare Bioscience (DARE) Expected to Announce Earnings on Monday - Defense World

Mar 23, 2026

Mar 20, 2026

Daré Bioscience to Host Full Year 2025 Financial Results and Company Update Conference Call and Webcast on March 26, 2026 - The Manila Times

Mar 20, 2026